InterMune’s Idiopathic Pulmonary Fibrosis Push Continues As Actimmune Sales Slump

Data support gambling on experimental pirfenidone against “incredibly complex” disease, chief scientific officer tells “The Pink Sheet” DAILY.

More from Archive

More from Pink Sheet